Name | Number of supported studies | Average coverage | |
---|---|---|---|
GABAergic neuron | 3 studies | 22% ± 2% | |
glutamatergic neuron | 3 studies | 27% ± 4% |
Insufficient scRNA-seq data for expression of NOCT at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 465.16 | 459 / 459 | 100% | 18.93 | 1113 / 1118 |
lung | 100% | 296.50 | 576 / 578 | 99% | 9.80 | 1142 / 1155 |
skin | 100% | 258.59 | 1802 / 1809 | 98% | 10.89 | 463 / 472 |
intestine | 96% | 149.14 | 923 / 966 | 96% | 7.24 | 508 / 527 |
stomach | 92% | 129.33 | 330 / 359 | 98% | 7.63 | 280 / 286 |
esophagus | 88% | 118.39 | 1274 / 1445 | 100% | 15.36 | 183 / 183 |
adrenal gland | 100% | 194.51 | 258 / 258 | 88% | 6.69 | 202 / 230 |
kidney | 98% | 287.08 | 87 / 89 | 90% | 8.60 | 811 / 901 |
brain | 92% | 149.49 | 2443 / 2642 | 95% | 5.39 | 670 / 705 |
uterus | 90% | 88.31 | 153 / 170 | 97% | 9.00 | 445 / 459 |
pancreas | 91% | 101.25 | 297 / 328 | 96% | 6.94 | 171 / 178 |
bladder | 90% | 119.10 | 19 / 21 | 95% | 8.24 | 477 / 504 |
liver | 100% | 621.04 | 225 / 226 | 76% | 6.03 | 310 / 406 |
prostate | 87% | 95.46 | 213 / 245 | 86% | 4.09 | 430 / 502 |
thymus | 99% | 163.73 | 646 / 653 | 73% | 2.85 | 441 / 605 |
ovary | 67% | 59.91 | 121 / 180 | 94% | 5.69 | 406 / 430 |
adipose | 100% | 559.82 | 1204 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 296.06 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 168.07 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.80 | 1 / 1 |
peripheral blood | 98% | 341.08 | 912 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 11.16 | 43 / 45 |
heart | 93% | 184.79 | 800 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 88% | 123.35 | 1181 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 86% | 6.39 | 25 / 29 |
eye | 0% | 0 | 0 / 0 | 59% | 2.94 | 47 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006366 | Biological process | transcription by RNA polymerase II |
GO_0006739 | Biological process | NADP metabolic process |
GO_0045995 | Biological process | regulation of embryonic development |
GO_0000290 | Biological process | deadenylation-dependent decapping of nuclear-transcribed mRNA |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0033962 | Biological process | P-body assembly |
GO_0048255 | Biological process | mRNA stabilization |
GO_0032922 | Biological process | circadian regulation of gene expression |
GO_0042752 | Biological process | regulation of circadian rhythm |
GO_0045600 | Biological process | positive regulation of fat cell differentiation |
GO_0045668 | Biological process | negative regulation of osteoblast differentiation |
GO_0032496 | Biological process | response to lipopolysaccharide |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005739 | Cellular component | mitochondrion |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000932 | Cellular component | P-body |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0019178 | Molecular function | NADP phosphatase activity |
GO_0003729 | Molecular function | mRNA binding |
GO_0102757 | Molecular function | NADPH phosphatase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0000175 | Molecular function | 3'-5'-RNA exonuclease activity |
GO_0004535 | Molecular function | poly(A)-specific ribonuclease activity |
Gene name | NOCT |
Protein name | Nocturnin (EC 3.1.3.108) (Carbon catabolite repression 4-like protein) CCR4 carbon catabolite repression 4-like (S. cerevisiae), isoform CRA_b (CCRN4L protein) (Nocturnin) |
Synonyms | CCRN4L hCG_1735627 CCR4 NOC |
Description | FUNCTION: Phosphatase which catalyzes the conversion of NADP(+) to NAD(+) and of NADPH to NADH . Shows a small preference for NADPH over NADP(+) . Represses translation and promotes degradation of target mRNA molecules . Plays an important role in post-transcriptional regulation of metabolic genes under circadian control (By similarity). Exerts a rhythmic post-transcriptional control of genes necessary for metabolic functions including nutrient absorption, glucose/insulin sensitivity, lipid metabolism, adipogenesis, inflammation and osteogenesis (By similarity). Plays an important role in favoring adipogenesis over osteoblastogenesis and acts as a key regulator of the adipogenesis/osteogenesis balance (By similarity). Promotes adipogenesis by facilitating PPARG nuclear translocation which activates its transcriptional activity (By similarity). Regulates circadian expression of NOS2 in the liver and negatively regulates the circadian expression of IGF1 in the bone (By similarity). Critical for proper development of early embryos (By similarity). . |
Accessions | ENST00000630479.1 ENST00000280614.4 Q8WTX0 Q9UK39 |